- £212.44m
- £207.64m
- £36.01m
- 99
- 17
- 95
- 84
2019 June 30th | 2020 June 30th | R2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.2 | 31.7 | 27.2 | 31.1 | 36 |
Cost of Revenue | |||||
Gross Profit | 20.7 | 25.2 | 22.7 | 24.9 | 29.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.5 | 24.9 | 23.9 | 29.4 | 30.7 |
Operating Profit | 4.7 | 6.8 | 3.38 | 1.75 | 5.28 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.75 | 6.64 | 2.38 | 1.55 | 5.11 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.03 | 5.1 | 1.59 | 0.987 | 4.46 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4.03 | 5.1 | 2.97 | 0.987 | 4.46 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 4.03 | 5.1 | 2.97 | 0.987 | 4.46 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.09 | 0.11 | 0.034 | 0.054 | 0.097 |
Dividends per Share | |||||
Special Dividends per Share |